首页 > 最新文献

International Journal of Nephrology最新文献

英文 中文
Test-Retest Reliability, Validity, and Minimal Detectable Change of the Measurement of Lower Limb Muscular Strength with Handheld Dynamometry in Patients Undergoing Hemodialysis. 用手持式测力仪测量血液透析患者下肢肌肉力量的重测信度、效度和最小可检测变化。
IF 2.1 Q3 UROLOGY & NEPHROLOGY Pub Date : 2022-06-15 eCollection Date: 2022-01-01 DOI: 10.1155/2022/5330608
Borja Perez-Dominguez, Aida Lopez-Brull, Maria Plaza-Carrasco, Jose Casaña-Granell, Alicia Garcia-Testal, Josep Benitez-Martinez

Background: Chronic kidney disease is an exponentially growing medical and economic worldwide problem. There are specific elements used to assess patient's functional capacity loss and overall deterioration in order to determine the patient's clinical status, and muscle impairment is one of the most common. It is therefore necessary to develop reliable and applicable methods to determine muscle impairment in patients with chronic kidney disease.

Methods: This is a prospective, nonexperimental, descriptive methodological investigation performed in patients undergoing hemodialysis. This study analyzes the reliability and validity of muscle strength assessments performed with handheld dynamometry in patients with chronic kidney disease undergoing hemodialysis.

Results: Results show overall high reliability and validity in the assessment of muscle strength of the lower limbs.

Conclusion: To our knowledge, this is the first study to assess handheld dynamometry in patients undergoing hemodialysis, presenting promising results with a relatively affordable and easily applicable method.

背景:慢性肾脏疾病是一个呈指数增长的世界性医学和经济问题。为了确定患者的临床状态,有一些特定的因素用于评估患者的功能丧失和整体恶化,肌肉损伤是最常见的因素之一。因此,有必要开发可靠和适用的方法来确定慢性肾脏疾病患者的肌肉损伤。方法:这是一项对血液透析患者进行的前瞻性、非实验性、描述性方法学调查。本研究分析了在接受血液透析的慢性肾脏疾病患者中使用手持式测力仪进行肌肉力量评估的信度和效度。结果:对下肢肌力的评估总体上具有较高的信度和效度。结论:据我们所知,这是第一个评估手持式动力测量在血液透析患者中的应用的研究,以一种相对负担得起且易于应用的方法呈现出有希望的结果。
{"title":"Test-Retest Reliability, Validity, and Minimal Detectable Change of the Measurement of Lower Limb Muscular Strength with Handheld Dynamometry in Patients Undergoing Hemodialysis.","authors":"Borja Perez-Dominguez,&nbsp;Aida Lopez-Brull,&nbsp;Maria Plaza-Carrasco,&nbsp;Jose Casaña-Granell,&nbsp;Alicia Garcia-Testal,&nbsp;Josep Benitez-Martinez","doi":"10.1155/2022/5330608","DOIUrl":"https://doi.org/10.1155/2022/5330608","url":null,"abstract":"<p><strong>Background: </strong>Chronic kidney disease is an exponentially growing medical and economic worldwide problem. There are specific elements used to assess patient's functional capacity loss and overall deterioration in order to determine the patient's clinical status, and muscle impairment is one of the most common. It is therefore necessary to develop reliable and applicable methods to determine muscle impairment in patients with chronic kidney disease.</p><p><strong>Methods: </strong>This is a prospective, nonexperimental, descriptive methodological investigation performed in patients undergoing hemodialysis. This study analyzes the reliability and validity of muscle strength assessments performed with handheld dynamometry in patients with chronic kidney disease undergoing hemodialysis.</p><p><strong>Results: </strong>Results show overall high reliability and validity in the assessment of muscle strength of the lower limbs.</p><p><strong>Conclusion: </strong>To our knowledge, this is the first study to assess handheld dynamometry in patients undergoing hemodialysis, presenting promising results with a relatively affordable and easily applicable method.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":" ","pages":"5330608"},"PeriodicalIF":2.1,"publicationDate":"2022-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217614/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40401626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Effects of Low-Flux and High-Flux Dialysis Membranes on Erythropoietin Responsiveness in Hemodialysis Patients. 低通量和高通量透析膜对血液透析患者促红细胞生成素反应性的影响。
IF 2.1 Q3 UROLOGY & NEPHROLOGY Pub Date : 2022-06-14 eCollection Date: 2022-01-01 DOI: 10.1155/2022/2984193
Walid A R Abdelhamid, Mohamed M Soliman, Ayman R A El-Hameed

Background: Chronic kidney disease (CKD) is often accompanied by anemia. High-flux membranes contribute to a reasonable removal of uremic toxins which cause anemia in CKD. Inadequate data have described the efficiency of high-flux dialysis in promoting erythropoietin responsiveness in CKD patients in the Middle East. This study was conducted to compare the efficiency of maintaining high-flux hemodialysis versus low-flux dialysis for ≥1 year in promoting erythropoietin responsiveness and to show the factors associated with erythropoietin hyporesponsiveness in Arab chronic hemodialysis patients.

Methods: It was a retrospective cohort study that involved 110 subjects who were categorized into group 1 (50 patients receiving low-flux dialysis) and group 2 (60 patients receiving high-flux dialysis). History taking, examination, and laboratory investigations were conducted for all patients every 3 months from January 2021 to January 2022.

Results: Group 2 had significantly higher weight and body mass index than group 1 but lower cholesterol and intact parathyroid hormone levels than group 1. Erythropoietin resistance index levels did not differ between the two groups upon repeated measures over a 1-year follow-up. Significant risk factors for erythropoietin hyporesponsiveness on multivariate analysis were lower weight (Odds ratio (OR): 0.966; 95% Confidence interval (CI): 0.94-0.992; p=0.011), longer hemodialysis vintage (OR: 1.172; 95% CI: 1.036-1.325; p=0.012), lower hemoglobin levels (OR: 0.531; 95% CI: 0.362-0.779; p=0.001), and higher neutrophil-to-lymphocyte ratio (OR: 2.436; 95% CI: 1.321-4.493; p=0.004).

Conclusion: High-flux dialysis was not superior to low-flux dialysis in improving erythropoietin responsiveness.

背景:慢性肾脏疾病(CKD)常伴有贫血。高通量膜有助于合理去除导致CKD贫血的尿毒症毒素。没有足够的数据描述高通量透析在促进中东CKD患者促红细胞生成素反应性方面的效率。本研究旨在比较维持高通量血液透析与低通量血液透析≥1年促进促红细胞生成素反应性的效率,并显示阿拉伯慢性血液透析患者促红细胞生成素低反应性的相关因素。方法:这是一项回顾性队列研究,涉及110名受试者,分为1组(50名接受低通量透析的患者)和2组(60名接受高通量透析的患者)。从2021年1月至2022年1月,每3个月对所有患者进行病史、检查和实验室调查。结果:2组患者体重、体质指数明显高于1组,胆固醇、甲状旁腺激素水平明显低于1组。在1年的反复随访中,两组的促红细胞生成素抵抗指数水平没有差异。多因素分析促红细胞生成素低反应性的显著危险因素为体重过轻(优势比(OR): 0.966;95%置信区间(CI): 0.94-0.992;p=0.011),较长的血液透析时间(OR: 1.172;95% ci: 1.036-1.325;p=0.012),血红蛋白水平降低(OR: 0.531;95% ci: 0.362-0.779;p=0.001),中性粒细胞与淋巴细胞比值较高(OR: 2.436;95% ci: 1.321-4.493;p = 0.004)。结论:高通量透析在提高促红细胞生成素反应性方面并不优于低通量透析。
{"title":"Effects of Low-Flux and High-Flux Dialysis Membranes on Erythropoietin Responsiveness in Hemodialysis Patients.","authors":"Walid A R Abdelhamid,&nbsp;Mohamed M Soliman,&nbsp;Ayman R A El-Hameed","doi":"10.1155/2022/2984193","DOIUrl":"https://doi.org/10.1155/2022/2984193","url":null,"abstract":"<p><strong>Background: </strong>Chronic kidney disease (CKD) is often accompanied by anemia. High-flux membranes contribute to a reasonable removal of uremic toxins which cause anemia in CKD. Inadequate data have described the efficiency of high-flux dialysis in promoting erythropoietin responsiveness in CKD patients in the Middle East. This study was conducted to compare the efficiency of maintaining high-flux hemodialysis versus low-flux dialysis for ≥1 year in promoting erythropoietin responsiveness and to show the factors associated with erythropoietin hyporesponsiveness in Arab chronic hemodialysis patients.</p><p><strong>Methods: </strong>It was a retrospective cohort study that involved 110 subjects who were categorized into group 1 (50 patients receiving low-flux dialysis) and group 2 (60 patients receiving high-flux dialysis). History taking, examination, and laboratory investigations were conducted for all patients every 3 months from January 2021 to January 2022.</p><p><strong>Results: </strong>Group 2 had significantly higher weight and body mass index than group 1 but lower cholesterol and intact parathyroid hormone levels than group 1. Erythropoietin resistance index levels did not differ between the two groups upon repeated measures over a 1-year follow-up. Significant risk factors for erythropoietin hyporesponsiveness on multivariate analysis were lower weight (Odds ratio (OR): 0.966; 95% Confidence interval (CI): 0.94-0.992; <i>p</i>=0.011), longer hemodialysis vintage (OR: 1.172; 95% CI: 1.036-1.325; <i>p</i>=0.012), lower hemoglobin levels (OR: 0.531; 95% CI: 0.362-0.779; <i>p</i>=0.001), and higher neutrophil-to-lymphocyte ratio (OR: 2.436; 95% CI: 1.321-4.493; <i>p</i>=0.004).</p><p><strong>Conclusion: </strong>High-flux dialysis was not superior to low-flux dialysis in improving erythropoietin responsiveness.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":" ","pages":"2984193"},"PeriodicalIF":2.1,"publicationDate":"2022-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213175/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40391243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health Facts Medication Adherence in Transplantation (H-MAT) Study: A Secondary Analysis of Determinants and Outcomes of Medication Nonadherence in Adult Kidney Transplant Recipients. 移植药物依从性(H-MAT)研究:成人肾移植受者药物依从性的决定因素和结果的二次分析。
IF 2.1 Q3 UROLOGY & NEPHROLOGY Pub Date : 2022-06-10 eCollection Date: 2022-01-01 DOI: 10.1155/2022/9653847
Cynthia L Russell, Heather J Gotham, An-Lin Cheng, Suman Sahil, Preethi Yerram

Aims: To explore the relationship between determinants and posttransplant medication nonadherence (MNA) in adult kidney transplant recipients, and to examine the relationship between posttransplant MNA and clinical outcomes.

Methods: Using the World Health Organization's model, this retrospective, multicenter, correlational study examined the relationship between determinants, posttransplant MNA, and clinical outcomes in 16,671 adult kidney transplant recipients from the Cerner Health Facts national data warehouse.

Results: With 12% MNA, those who were nonadherent were more likely to have the social/economic factors of being younger, single, Caucasian versus Hispanic race, have the condition-related factor of mental health/substance use disorder, and have the healthcare system-related factor of government/health maintenance organization/managed care insurance (p's < 0.05). Bivariate correlations indicated both age (OR = 1.006, p=0.01) and mental health or substance use disorder diagnosis (OR = 1.26, p=0.04) were significant predictors of MNA. Patients were 0.6% more likely to be medication adherent for each year they increased in age and 26% more likely to be MNA if they were diagnosed with a mental health/substance use disorder. Nonadherent patients were less likely to be readmitted, but more likely to have complications after transplant and medication side effects (p's < 0.01).

Conclusions: Using one of the largest samples of adult kidney transplant patients, our findings support the WHO model and move the body of medication adherence intervention research forward by clarifying the importance of focusing interventions not only on the patient but on multilevel determinants. Consistent with previous studies, MNA negatively impacts transplant outcomes.

目的:探讨成人肾移植受者移植后药物依从性(MNA)与决定因素之间的关系,并探讨移植后MNA与临床结果的关系。方法:使用世界卫生组织的模型,这项回顾性、多中心、相关研究检查了来自Cerner Health Facts国家数据仓库的16,671名成人肾移植受者的决定因素、移植后MNA和临床结果之间的关系。结果:当MNA为12%时,非依从性患者更容易出现年轻、单身、白种人与西班牙裔等社会/经济因素,更容易出现精神健康/物质使用障碍等条件相关因素,更容易出现政府/健康维护机构/管理式医疗保险等医疗系统相关因素(p < 0.05)。双变量相关性显示,年龄(OR = 1.006, p=0.01)和精神健康或物质使用障碍诊断(OR = 1.26, p=0.04)是MNA的显著预测因子。年龄每增加一年,患者坚持服药的可能性增加0.6%,如果被诊断患有精神健康/物质使用障碍,则成为MNA的可能性增加26%。非依从性患者再入院的可能性较小,但移植后并发症和药物副作用的可能性较大(p < 0.01)。结论:使用最大的成人肾移植患者样本之一,我们的研究结果支持世卫组织模型,并通过阐明将干预重点不仅放在患者身上,而且放在多层决定因素上的重要性,推动了药物依从性干预研究的发展。与先前的研究一致,MNA对移植结果有负面影响。
{"title":"Health Facts Medication Adherence in Transplantation (H-MAT) Study: A Secondary Analysis of Determinants and Outcomes of Medication Nonadherence in Adult Kidney Transplant Recipients.","authors":"Cynthia L Russell,&nbsp;Heather J Gotham,&nbsp;An-Lin Cheng,&nbsp;Suman Sahil,&nbsp;Preethi Yerram","doi":"10.1155/2022/9653847","DOIUrl":"https://doi.org/10.1155/2022/9653847","url":null,"abstract":"<p><strong>Aims: </strong>To explore the relationship between determinants and posttransplant medication nonadherence (MNA) in adult kidney transplant recipients, and to examine the relationship between posttransplant MNA and clinical outcomes.</p><p><strong>Methods: </strong>Using the World Health Organization's model, this retrospective, multicenter, correlational study examined the relationship between determinants, posttransplant MNA, and clinical outcomes in 16,671 adult kidney transplant recipients from the Cerner <i>Health Facts</i> national data warehouse.</p><p><strong>Results: </strong>With 12% MNA, those who were nonadherent were more likely to have the social/economic factors of being younger, single, Caucasian versus Hispanic race, have the condition-related factor of mental health/substance use disorder, and have the healthcare system-related factor of government/health maintenance organization/managed care insurance (<i>p</i>'<i>s</i> < 0.05). Bivariate correlations indicated both age (OR = 1.006, <i>p</i>=0.01) and mental health or substance use disorder diagnosis (OR = 1.26, <i>p</i>=0.04) were significant predictors of MNA. Patients were 0.6% more likely to be medication adherent for each year they increased in age and 26% more likely to be MNA if they were diagnosed with a mental health/substance use disorder. Nonadherent patients were less likely to be readmitted, but more likely to have complications after transplant and medication side effects (<i>p</i>'<i>s</i> < 0.01).</p><p><strong>Conclusions: </strong>Using one of the largest samples of adult kidney transplant patients, our findings support the WHO model and move the body of medication adherence intervention research forward by clarifying the importance of focusing interventions not only on the patient but on multilevel determinants. Consistent with previous studies, MNA negatively impacts transplant outcomes.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":" ","pages":"9653847"},"PeriodicalIF":2.1,"publicationDate":"2022-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205738/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40041954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A Comprehensive Comparison of Clinical Presentation and Outcomes of Kidney Transplant Recipients with COVID-19 during Wave 1 versus Wave 2 at a Tertiary Care Center, India 印度三级护理中心新冠肺炎肾移植受者在第1波和第2波期间的临床表现和结果的综合比较
IF 2.1 Q3 UROLOGY & NEPHROLOGY Pub Date : 2022-06-02 DOI: 10.1155/2022/9088393
S. Jasuja, G. Sagar, A. Bahl, Neharita Jasuja, R. Chawla, A. Bansal, M. Kanwar, S. Kansal, N. Modi, A. Ansari, Viny Kantroo, P. Dhar, C. Chatterjee, N. Ghonge, Samir Tawakley, Shalini Verma
Data comparing the clinical spectrum of COVID-19 in kidney transplant recipients (KTRs) during the first and second waves of the pandemic in India is limited. Our single-center retrospective study compared the clinical profile, mortality, and associated risk factors in KTRs with COVID-19 during the 1st wave (1st February 2020 to 31st January 2021) and the second wave (1st March-31st August 2021). 156 KTRs with PCR confirmed SARS-CoV-2 infection treated at a tertiary care hospital in New Delhi during the 1st and the second waves were analyzed. The demographics and baseline transplant characteristics of the patients diagnosed during both waves were comparable. Patients in the second wave reported less frequent hospitalization, though the intensive care unit (ICU) and ventilator requirements were similar. Strategies to modify immunosuppressants such as discontinuation of antinucleoside drugs with or without change in calcineurin inhibitors and the use of steroids were similar during both waves. Overall patient mortality was 27.5%. The demographics and baseline characteristics of survivors and nonsurvivors were comparable. A higher percentage of nonsurvivors presented with breathing difficulty, low SpO2, and altered sensorium. Both wave risk factors for mortality included older age, severe disease, ICU/ventilator requirements, acute kidney injury (AKI) needing dialysis, Chest Computerized Tomographic (CT) scan abnormalities, and higher levels of inflammatory markers particularly D-dimer and interleukin-6 levels. Conclusions. KTRs in both COVID-19 waves had similar demographics and baseline characteristics, while fewer patients during the second wave required hospitalization. The D-dimer and IL-6 levels are directly correlated with mortality.
比较印度第一波和第二波疫情期间肾移植受者(KTR)中新冠肺炎临床谱的数据有限。我们的单中心回顾性研究比较了第一波(2020年2月1日至2021年1月31日)和第二波(2021年3月1日到8月31日,)期间新冠肺炎KTR的临床特征、死亡率和相关风险因素。对第一波和第二波期间在新德里一家三级护理医院接受治疗的156名经PCR确诊的严重急性呼吸系统综合征冠状病毒2型感染者进行了分析。两波中诊断的患者的人口统计学和基线移植特征具有可比性。第二波患者的住院频率较低,尽管重症监护室(ICU)和呼吸机的要求相似。改变免疫抑制剂的策略,如停用抗核苷药物,同时或不改变钙调神经磷酸酶抑制剂,以及使用类固醇,在这两波中是相似的。患者总死亡率为27.5%。幸存者和非幸存者的人口统计学和基线特征具有可比性。更高比例的非幸存者出现呼吸困难、血氧饱和度低和感觉改变。死亡的两个波动风险因素包括年龄较大、严重疾病、ICU/呼吸机需求、需要透析的急性肾损伤(AKI)、胸部计算机断层扫描(CT)异常以及较高水平的炎症标志物,特别是D-二聚体和白细胞介素-6水平。结论。新冠肺炎两波中的KTR具有相似的人口统计学和基线特征,而第二波中需要住院治疗的患者较少。D-二聚体和IL-6水平与死亡率直接相关。
{"title":"A Comprehensive Comparison of Clinical Presentation and Outcomes of Kidney Transplant Recipients with COVID-19 during Wave 1 versus Wave 2 at a Tertiary Care Center, India","authors":"S. Jasuja, G. Sagar, A. Bahl, Neharita Jasuja, R. Chawla, A. Bansal, M. Kanwar, S. Kansal, N. Modi, A. Ansari, Viny Kantroo, P. Dhar, C. Chatterjee, N. Ghonge, Samir Tawakley, Shalini Verma","doi":"10.1155/2022/9088393","DOIUrl":"https://doi.org/10.1155/2022/9088393","url":null,"abstract":"Data comparing the clinical spectrum of COVID-19 in kidney transplant recipients (KTRs) during the first and second waves of the pandemic in India is limited. Our single-center retrospective study compared the clinical profile, mortality, and associated risk factors in KTRs with COVID-19 during the 1st wave (1st February 2020 to 31st January 2021) and the second wave (1st March-31st August 2021). 156 KTRs with PCR confirmed SARS-CoV-2 infection treated at a tertiary care hospital in New Delhi during the 1st and the second waves were analyzed. The demographics and baseline transplant characteristics of the patients diagnosed during both waves were comparable. Patients in the second wave reported less frequent hospitalization, though the intensive care unit (ICU) and ventilator requirements were similar. Strategies to modify immunosuppressants such as discontinuation of antinucleoside drugs with or without change in calcineurin inhibitors and the use of steroids were similar during both waves. Overall patient mortality was 27.5%. The demographics and baseline characteristics of survivors and nonsurvivors were comparable. A higher percentage of nonsurvivors presented with breathing difficulty, low SpO2, and altered sensorium. Both wave risk factors for mortality included older age, severe disease, ICU/ventilator requirements, acute kidney injury (AKI) needing dialysis, Chest Computerized Tomographic (CT) scan abnormalities, and higher levels of inflammatory markers particularly D-dimer and interleukin-6 levels. Conclusions. KTRs in both COVID-19 waves had similar demographics and baseline characteristics, while fewer patients during the second wave required hospitalization. The D-dimer and IL-6 levels are directly correlated with mortality.","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48441133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Comparison of Laboratory Diagnosis of Urinary Tract Infections Based on Leukocyte and Bacterial Parameters Using Standardized Microscopic and Flow Cytometry Methods 基于白细胞和细菌参数的尿路感染标准化显微镜和流式细胞术实验室诊断的比较
IF 2.1 Q3 UROLOGY & NEPHROLOGY Pub Date : 2022-05-27 DOI: 10.1155/2022/9555121
Priskila Christy, H. Sidjabat, Anggia Augustasia Lumban Toruan, E. Moses, N. Mohd Yussof, Yessy Puspitasari, M. R. Fuadi, Aryati, F. R. Marpaung
Background Rapid and reliable tests are essential for the diagnostic laboratory confirmation of urinary tract infections (UTIs). Until now, UTI has been confirmed by the microbiology culture of urine, requiring at least 48-hour turnaround time (TAT), with a standardized microscopic method being widely favored. Automated urine flow cytometry, however, has recently been used to improve the rapid TAT by analyzing the urine sediment. This study therefore aimed to compare the diagnostic value of the Shih-Yung conventional microscopic and urine flow cytometry methods in the detection of leukocyte and bacterial parameters of patients with UTIs in an outpatient clinic. Methods A cross-sectional study was conducted on a total of 100 patients. Seventy urine samples were positive for leukocytes and nitrite chemistry, and 30 were negative for both. The measurements of urine leukocytes and bacteria were compared between Sysmex UF-5000 urine flow cytometry and the Shih-Yung method. The diagnostic value was obtained from ROC analysis of urine flow cytometry and the culture. Results A leukocyte cutoff value of 87.2/μL had a sensitivity and specificity of 98.33% and 95%, respectively, and 98.33% sensitivity and 75% specificity at a bacterial cutoff of 582.22/μL. Interestingly, our study identified strong and consistent agreement of leukocyte and bacterial parameters between urine flow cytometry and Shih-Yung (k = 0.959, p < 0.001 and k = 0.939, p < 0.001, respectively). Furthermore, through analyzing the dominance angle of the scattergram, a strong agreement was obtained with the culture result (k = 0.880, p < 0.001). Conclusions The Shih-Yung method showed consistent agreement with urine flow cytometry for the detection of leukocytes and bacteria. The use of certain cutoffs for bacterial and leukocyte parameters in urine flow cytometry demonstrated very good performance in detecting acquired symptomatic UTIs.
背景快速可靠的检测对于诊断实验室确认尿路感染(UTIs)至关重要。到目前为止,尿路感染已经通过尿液的微生物培养得到证实,至少需要48小时的周转时间(TAT),标准化显微镜方法广受欢迎。然而,自动化尿液流式细胞术最近已被用于通过分析尿液沉积物来提高快速TAT。因此,本研究旨在比较施勇常规显微镜和尿液流式细胞术方法在门诊UTI患者白细胞和细菌参数检测中的诊断价值。方法对100例患者进行横断面研究。70份尿液样本的白细胞和亚硝酸盐化学检测呈阳性,30份同时呈阴性。比较Sysmex UF-5000尿液流式细胞仪和Shih-Yung方法对尿液白细胞和细菌的测量。通过尿液流式细胞仪和培养物的ROC分析获得诊断价值。结果白细胞临界值87.2/μL的敏感性和特异性分别为98.33%和95%,细菌临界值582.22/μL的灵敏度和特异性为98.33%,特异性为75% = 0.959,p<0.001和k = 0.939,p<0.001)。此外,通过分析散点图的优势角,与培养结果(k = 0.880,p<0.001)。在尿液流式细胞术中使用某些细菌和白细胞参数的截止值在检测获得性症状性尿路感染方面表现出非常好的性能。
{"title":"Comparison of Laboratory Diagnosis of Urinary Tract Infections Based on Leukocyte and Bacterial Parameters Using Standardized Microscopic and Flow Cytometry Methods","authors":"Priskila Christy, H. Sidjabat, Anggia Augustasia Lumban Toruan, E. Moses, N. Mohd Yussof, Yessy Puspitasari, M. R. Fuadi, Aryati, F. R. Marpaung","doi":"10.1155/2022/9555121","DOIUrl":"https://doi.org/10.1155/2022/9555121","url":null,"abstract":"Background Rapid and reliable tests are essential for the diagnostic laboratory confirmation of urinary tract infections (UTIs). Until now, UTI has been confirmed by the microbiology culture of urine, requiring at least 48-hour turnaround time (TAT), with a standardized microscopic method being widely favored. Automated urine flow cytometry, however, has recently been used to improve the rapid TAT by analyzing the urine sediment. This study therefore aimed to compare the diagnostic value of the Shih-Yung conventional microscopic and urine flow cytometry methods in the detection of leukocyte and bacterial parameters of patients with UTIs in an outpatient clinic. Methods A cross-sectional study was conducted on a total of 100 patients. Seventy urine samples were positive for leukocytes and nitrite chemistry, and 30 were negative for both. The measurements of urine leukocytes and bacteria were compared between Sysmex UF-5000 urine flow cytometry and the Shih-Yung method. The diagnostic value was obtained from ROC analysis of urine flow cytometry and the culture. Results A leukocyte cutoff value of 87.2/μL had a sensitivity and specificity of 98.33% and 95%, respectively, and 98.33% sensitivity and 75% specificity at a bacterial cutoff of 582.22/μL. Interestingly, our study identified strong and consistent agreement of leukocyte and bacterial parameters between urine flow cytometry and Shih-Yung (k = 0.959, p < 0.001 and k = 0.939, p < 0.001, respectively). Furthermore, through analyzing the dominance angle of the scattergram, a strong agreement was obtained with the culture result (k = 0.880, p < 0.001). Conclusions The Shih-Yung method showed consistent agreement with urine flow cytometry for the detection of leukocytes and bacteria. The use of certain cutoffs for bacterial and leukocyte parameters in urine flow cytometry demonstrated very good performance in detecting acquired symptomatic UTIs.","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44932771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Continuous Infusion of Iohexol to Monitor Perioperative Glomerular Filtration Rate. 持续输注碘海醇监测围手术期肾小球滤过率
IF 1.7 Q3 UROLOGY & NEPHROLOGY Pub Date : 2022-05-24 eCollection Date: 2022-01-01 DOI: 10.1155/2022/8267829
Kjellbjørn Jakobsen, Bjørn O Eriksen, Ole M Fuskevåg, Stephen J Hodges, Lars M Ytrebø

Continuous monitoring of the glomerular filtration rate (GFR) in the perioperative setting could provide valuable information about acute kidney injury risk for both clinical and research purposes. This pilot study aimed to demonstrate that GFR measurement by a continuous 72 hrs iohexol infusion in patients undergoing colorectal cancer surgery is feasible. Four patients undergoing robot-assisted colorectal cancer surgery were recruited from elective surgery listings. GFR was determined preoperatively by the single-sample iohexol clearance method, and postoperatively at timed intervals by a continuous iohexol infusion for 72 hrs. Plasma concentrations of creatinine and cystatin C were measured concurrently. GFR was calculated as (iohexol infusion rate (mg/min))/(plasma iohexol concentration (mg/mL)). The association of the three different filtration markers and GFR with time were analysed in generalized additive mixed models. The continuous infusion of iohexol was established in all four patients and maintained throughout the study period without interfering with ordinary postoperative care. Postoperative GFR at 2 hours were elevated compared to the preoperative measurements for patients 1, 2, and 3, but not for patient 4. Whereas patients 1, 2, and 3 had u-shaped postoperative mGFR curves, patient 4 demonstrated a linear increase in mGFR with time. We conclude that obtaining continuous measurements of GFR in the postoperative setting is feasible and can detect variations in GFR. The method can be used as a tool to track perioperative changes in renal function.

在围手术期持续监测肾小球滤过率(GFR)可以为临床和研究目的提供有关急性肾损伤风险的有价值的信息。这项试点研究旨在证明通过连续72 hrs碘己醇输注在癌症大肠癌手术患者中是可行的。从选择性手术列表中招募了四名接受机器人辅助癌症结直肠癌手术的患者。GFR在术前通过单样本碘海醇清除法测定,术后通过连续输注碘海醇72 同时测量肌酸酐和胱抑素C的血浆浓度。GFR计算为(碘海醇输注速率(mg/min))/(血浆碘海醇浓度(mg/mL))。在广义加性混合模型中分析了三种不同过滤标志物和GFR与时间的相关性。在所有四名患者中均建立了碘海醇的持续输注,并在整个研究期间保持输注,而不干扰普通的术后护理。与患者1、2和3的术前测量值相比,术后2小时的GFR升高,但患者4没有升高。患者1、2和3的术后mGFR曲线呈u形,而患者4的mGFR随时间呈线性增加。我们的结论是,在术后环境中连续测量GFR是可行的,并且可以检测GFR的变化。该方法可作为追踪围手术期肾功能变化的工具。
{"title":"Continuous Infusion of Iohexol to Monitor Perioperative Glomerular Filtration Rate.","authors":"Kjellbjørn Jakobsen, Bjørn O Eriksen, Ole M Fuskevåg, Stephen J Hodges, Lars M Ytrebø","doi":"10.1155/2022/8267829","DOIUrl":"10.1155/2022/8267829","url":null,"abstract":"<p><p>Continuous monitoring of the glomerular filtration rate (GFR) in the perioperative setting could provide valuable information about acute kidney injury risk for both clinical and research purposes. This pilot study aimed to demonstrate that GFR measurement by a continuous 72 hrs iohexol infusion in patients undergoing colorectal cancer surgery is feasible. Four patients undergoing robot-assisted colorectal cancer surgery were recruited from elective surgery listings. GFR was determined preoperatively by the single-sample iohexol clearance method, and postoperatively at timed intervals by a continuous iohexol infusion for 72 hrs. Plasma concentrations of creatinine and cystatin C were measured concurrently. GFR was calculated as (iohexol infusion rate (mg/min))/(plasma iohexol concentration (mg/mL)). The association of the three different filtration markers and GFR with time were analysed in generalized additive mixed models. The continuous infusion of iohexol was established in all four patients and maintained throughout the study period without interfering with ordinary postoperative care. Postoperative GFR at 2 hours were elevated compared to the preoperative measurements for patients 1, 2, and 3, but not for patient 4. Whereas patients 1, 2, and 3 had u-shaped postoperative mGFR curves, patient 4 demonstrated a linear increase in mGFR with time. We conclude that obtaining continuous measurements of GFR in the postoperative setting is feasible and can detect variations in GFR. The method can be used as a tool to track perioperative changes in renal function.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2022 1","pages":"8267829"},"PeriodicalIF":1.7,"publicationDate":"2022-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155923/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41340962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge and Risk Perceptions of Chronic Kidney Disease Risk Factors among Women of Childbearing Age in Lagos State, Nigeria: From a Health Demography Approach 尼日利亚拉各斯州育龄妇女对慢性肾脏疾病危险因素的认识和风险认知:从健康人口学角度
IF 2.1 Q3 UROLOGY & NEPHROLOGY Pub Date : 2022-05-19 DOI: 10.1155/2022/5511555
M. Akokuwebe, E. Idemudia
Background Kidney disease (KD), also known as chronic kidney disease (CKD), is a long-term underrecognized public health concern and one of the eight leading causes of death in women. Despite that, little is known about women's knowledge, perceived risk, and perceptions of CKD risk factors. In this study, we assessed knowledge, perceived risk, and perceptions of CKD risk factors among women of childbearing age in Lagos State, Nigeria. Methods Administering a pretested and structured questionnaire among 825 women aged 15–49 years, we conducted a cross-sectional descriptive study to evaluate knowledge, self-reported CKD risk factors, and risk perception among women of childbearing age in urban and semiurban communities in Lagos State, Nigeria. We used descriptive (mean, frequencies, and percentages) and bivariate statistics (chi-square) to assess sociodemographic factors influencing knowledge and perceptions of CKD risk factors. Binary and multinomial logistic regressions were further employed to assess risk perceptions of CKD factors associated with knowledge. Results Five hundred and forty (65.5%) out of 825 women reported being knowledgeable of CKD risk factors with majority of the younger adult women (15–29 years) having good knowledge than other age cohorts, with a mean age of 33.5 ± 11.5 years. The women's knowledge of CKD was found to be significantly associated with independent and dependent risk factors (p < 0.05). The major self-reported independent CKD risk factors were misuse of analgesics (NSAIDs) (OR = 1.20; p < 0.05), herbal drinks (OR = 2.30; p < 0.05), and herbal supplements (OR = 1.37; p < 0.05), while self-reported dependent CKD risk factors were hypertension (OR = 2.14; p < 0.05), family history of KD ailments (OR = 1.30; p < 0.05), and high cholesterol (OR = 1.44; p < 0.05). Similarly, majority of the women had low perceived CKD risk (54.8%), while women with CKD risk factors (independent and dependent) view themselves at decreased perceived risk for the disease compared to those who are not associated with CKD risk factors (p < 0.05). Also, findings revealed that women had poor perception of risk factors associated with CKD. The multivariate analysis of perceived risk showed that demographic factors (younger aged adults, high education, and high income), independent risk factors of CKD (misuse of NASAIDs and excessive use of herbal drink and herbal supplement), and dependent risk factors (hypertension and family history of KD ailments) were significantly associated with knowledge of CKD (p < 0.05). Conclusion Our study reveals high knowledge of CKD risk factors but low perceived risk and poor perception of the link between CKD risk factors and its ailments. Given this, there is a call for urgent measures to create sensitization and provide public CKD behavioural health interventions as well as easy communication strategies for women to secure better access to awareness intervention programmes and healthcare services.
肾脏疾病(KD),也被称为慢性肾脏疾病(CKD),是一个长期未被充分认识的公共卫生问题,也是女性死亡的八大原因之一。尽管如此,我们对女性的认知、感知风险以及对CKD危险因素的认知知之甚少。在这项研究中,我们评估了尼日利亚拉各斯州育龄妇女对CKD危险因素的认知、感知风险和认知。方法对尼日利亚拉各斯州城市和半城市社区的825名年龄在15-49岁的妇女进行预测试和结构化问卷调查,进行横断面描述性研究,以评估知识,自我报告的CKD危险因素以及育龄妇女的风险认知。我们使用描述性(平均值、频率和百分比)和双变量统计(卡方)来评估影响CKD危险因素知识和认知的社会人口因素。进一步采用二元和多项逻辑回归来评估与知识相关的CKD因素的风险认知。结果825名女性中有540人(65.5%)报告了解CKD危险因素,其中15-29岁的年轻成年女性比其他年龄段的女性了解更多,平均年龄为33.5±11.5岁。女性对CKD的认知与独立、依赖危险因素显著相关(p < 0.05)。自我报告的主要独立CKD危险因素是滥用镇痛药(NSAIDs) (OR = 1.20;p < 0.05),草药饮料(OR = 2.30;p < 0.05),草药补充剂(OR = 1.37;p < 0.05),而自我报告的依赖性CKD危险因素为高血压(OR = 2.14;p < 0.05), KD疾病家族史(OR = 1.30;p < 0.05),高胆固醇(OR = 1.44;p < 0.05)。同样,大多数女性的CKD风险感知较低(54.8%),而有CKD风险因素(独立和依赖)的女性认为自己患CKD的风险感知比没有CKD风险因素的女性低(p < 0.05)。此外,研究结果显示,女性对CKD相关危险因素的认识较差。感知风险的多因素分析显示,人口统计学因素(年轻、高学历、高收入)、CKD独立危险因素(滥用NASAIDs、过度使用草药饮料和草药补充剂)、依赖危险因素(高血压和KD家族史)与CKD知识显著相关(p < 0.05)。结论我们的研究揭示了对CKD危险因素的认识较高,但认知风险较低,对CKD危险因素与疾病之间的联系认识较差。鉴于此,有必要采取紧急措施,提高认识,提供公共CKD行为健康干预措施,并为妇女提供方便的沟通战略,以确保更好地获得认识干预方案和保健服务。
{"title":"Knowledge and Risk Perceptions of Chronic Kidney Disease Risk Factors among Women of Childbearing Age in Lagos State, Nigeria: From a Health Demography Approach","authors":"M. Akokuwebe, E. Idemudia","doi":"10.1155/2022/5511555","DOIUrl":"https://doi.org/10.1155/2022/5511555","url":null,"abstract":"Background Kidney disease (KD), also known as chronic kidney disease (CKD), is a long-term underrecognized public health concern and one of the eight leading causes of death in women. Despite that, little is known about women's knowledge, perceived risk, and perceptions of CKD risk factors. In this study, we assessed knowledge, perceived risk, and perceptions of CKD risk factors among women of childbearing age in Lagos State, Nigeria. Methods Administering a pretested and structured questionnaire among 825 women aged 15–49 years, we conducted a cross-sectional descriptive study to evaluate knowledge, self-reported CKD risk factors, and risk perception among women of childbearing age in urban and semiurban communities in Lagos State, Nigeria. We used descriptive (mean, frequencies, and percentages) and bivariate statistics (chi-square) to assess sociodemographic factors influencing knowledge and perceptions of CKD risk factors. Binary and multinomial logistic regressions were further employed to assess risk perceptions of CKD factors associated with knowledge. Results Five hundred and forty (65.5%) out of 825 women reported being knowledgeable of CKD risk factors with majority of the younger adult women (15–29 years) having good knowledge than other age cohorts, with a mean age of 33.5 ± 11.5 years. The women's knowledge of CKD was found to be significantly associated with independent and dependent risk factors (p < 0.05). The major self-reported independent CKD risk factors were misuse of analgesics (NSAIDs) (OR = 1.20; p < 0.05), herbal drinks (OR = 2.30; p < 0.05), and herbal supplements (OR = 1.37; p < 0.05), while self-reported dependent CKD risk factors were hypertension (OR = 2.14; p < 0.05), family history of KD ailments (OR = 1.30; p < 0.05), and high cholesterol (OR = 1.44; p < 0.05). Similarly, majority of the women had low perceived CKD risk (54.8%), while women with CKD risk factors (independent and dependent) view themselves at decreased perceived risk for the disease compared to those who are not associated with CKD risk factors (p < 0.05). Also, findings revealed that women had poor perception of risk factors associated with CKD. The multivariate analysis of perceived risk showed that demographic factors (younger aged adults, high education, and high income), independent risk factors of CKD (misuse of NASAIDs and excessive use of herbal drink and herbal supplement), and dependent risk factors (hypertension and family history of KD ailments) were significantly associated with knowledge of CKD (p < 0.05). Conclusion Our study reveals high knowledge of CKD risk factors but low perceived risk and poor perception of the link between CKD risk factors and its ailments. Given this, there is a call for urgent measures to create sensitization and provide public CKD behavioural health interventions as well as easy communication strategies for women to secure better access to awareness intervention programmes and healthcare services.","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44466361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Analysis of Various Types of Glomerulonephritis with Crescents at a Single Center 以Crescens为单一中心的不同类型肾小球肾炎的分析
IF 2.1 Q3 UROLOGY & NEPHROLOGY Pub Date : 2022-05-09 DOI: 10.1155/2022/1749548
T. Nakakita, K. Akiyama, Kazunori Karasawa, Yoei Miyabe, T. Moriyama, K. Uchida, K. Nitta
Background The importance of crescent formation in glomerulonephritis has increased. However, detailed analysis of crescentic glomerulonephritis in Asia is scarce. In addition, advances in serological diagnostic techniques (antineutrophil cytoplasmic and antiglomerular basement membrane autoantibodies) and early diagnosis have reduced the number of cases meeting the strict definition of crescentic glomerulonephritis (>50% of glomeruli are crescentic). Therefore, we analyzed the clinicopathological features and renal prognosis of glomerulonephritis cases that exhibited at least one crescentic lesion. Methods We retrospectively evaluated 265 adult patients diagnosed with glomerulonephritis with at least one crescent formation based on the results of renal biopsy. We divided the patients into two groups based on the four types of glomerulonephritis, namely, the immune-complex (type II: IgA nephropathy, IgA vasculitis with nephritis, and lupus nephritis) and pauci-immune (type III: microscopic polyangiitis) groups. Factors affecting renal prognosis (end-stage renal failure requiring renal replacement therapy) were examined in a multivariate analysis using the Cox proportional hazards model. Kaplan–Meier curves and log-rank test were used to analyze and compare time from entry to renal death. Results Renal prognosis differed significantly between the immune-complex and pauci-immune groups. Among the four types of glomerulonephritis, IgA nephropathy was the most prevalent. Multivariate analysis showed that renal function at renal biopsy and the ratio of global sclerosis independently predicted renal prognosis, but the type of glomerulonephritis was not a factor. Conclusions Renal dysfunction at renal biopsy and the ratio of global sclerosis predicted renal prognosis, because it reflects the degree of irreversible renal damage. We also suspect that the formation of at least one crescentic lesion led to the development of these predictive factors, regardless of the type of glomerular disease and degree of crescent formation.
背景新月形形成在肾小球肾炎中的重要性已经增加。然而,对亚洲新月体肾小球肾炎的详细分析却很少。此外,血清学诊断技术(抗中性粒细胞细胞质和抗肾小球基底膜自身抗体)和早期诊断的进步减少了符合新月体肾小球肾炎严格定义的病例数量(>50%的肾小球是新月体肾小球)。因此,我们分析了至少有一个新月形病变的肾小球肾炎病例的临床病理特征和肾脏预后。方法根据肾活检结果,对265例诊断为至少有一个新月形肾小球肾炎的成年患者进行回顾性评价。我们根据肾小球肾炎的四种类型将患者分为两组,即免疫复合物组(II型:IgA肾病、IgA血管炎伴肾炎和狼疮性肾炎)和缺乏免疫组(III型:显微镜下多血管炎)。使用Cox比例风险模型进行多变量分析,检查影响肾脏预后的因素(需要肾脏替代治疗的终末期肾衰竭)。Kaplan–Meier曲线和log秩检验用于分析和比较从进入肾死亡到死亡的时间。结果免疫复合物组和缺乏免疫组的肾脏预后差异显著。在四种类型的肾小球肾炎中,IgA肾病最为常见。多因素分析显示,肾活检时的肾功能和全身硬化症的比例独立预测肾脏预后,但肾小球肾炎的类型不是一个因素。结论肾活检时肾功能不全和全硬化率可预测肾脏预后,因为它反映了不可逆性肾损伤的程度。我们还怀疑,无论肾小球疾病的类型和新月形形成的程度如何,至少一个新月形病变的形成都会导致这些预测因素的发展。
{"title":"Analysis of Various Types of Glomerulonephritis with Crescents at a Single Center","authors":"T. Nakakita, K. Akiyama, Kazunori Karasawa, Yoei Miyabe, T. Moriyama, K. Uchida, K. Nitta","doi":"10.1155/2022/1749548","DOIUrl":"https://doi.org/10.1155/2022/1749548","url":null,"abstract":"Background The importance of crescent formation in glomerulonephritis has increased. However, detailed analysis of crescentic glomerulonephritis in Asia is scarce. In addition, advances in serological diagnostic techniques (antineutrophil cytoplasmic and antiglomerular basement membrane autoantibodies) and early diagnosis have reduced the number of cases meeting the strict definition of crescentic glomerulonephritis (>50% of glomeruli are crescentic). Therefore, we analyzed the clinicopathological features and renal prognosis of glomerulonephritis cases that exhibited at least one crescentic lesion. Methods We retrospectively evaluated 265 adult patients diagnosed with glomerulonephritis with at least one crescent formation based on the results of renal biopsy. We divided the patients into two groups based on the four types of glomerulonephritis, namely, the immune-complex (type II: IgA nephropathy, IgA vasculitis with nephritis, and lupus nephritis) and pauci-immune (type III: microscopic polyangiitis) groups. Factors affecting renal prognosis (end-stage renal failure requiring renal replacement therapy) were examined in a multivariate analysis using the Cox proportional hazards model. Kaplan–Meier curves and log-rank test were used to analyze and compare time from entry to renal death. Results Renal prognosis differed significantly between the immune-complex and pauci-immune groups. Among the four types of glomerulonephritis, IgA nephropathy was the most prevalent. Multivariate analysis showed that renal function at renal biopsy and the ratio of global sclerosis independently predicted renal prognosis, but the type of glomerulonephritis was not a factor. Conclusions Renal dysfunction at renal biopsy and the ratio of global sclerosis predicted renal prognosis, because it reflects the degree of irreversible renal damage. We also suspect that the formation of at least one crescentic lesion led to the development of these predictive factors, regardless of the type of glomerular disease and degree of crescent formation.","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48087537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Diabetic Retinopathy Is a Predictor of Progression of Diabetic Kidney Disease: A Systematic Review and Meta-Analysis 糖尿病视网膜病变是糖尿病肾病进展的预测因子:一项系统综述和荟萃分析
IF 2.1 Q3 UROLOGY & NEPHROLOGY Pub Date : 2022-04-29 DOI: 10.1155/2022/3922398
Mansi Gupta, I. Rao, S. Nagaraju, S. Bhandary, Jayanti Gupta, Ganesh T. C. Babu
Methods A systematic search was conducted on PubMed, Embase, and the Google scholar for eligible studies through September 2021. The quality of selected articles was assessed using JBI checklist. Higgins and Thompson's I2 statistic was used to see the degree of heterogeneity. Based on degree of heterogeneity, fixed or random effects model was used to estimate pooled effect using inverse variance method. Results were expressed as hazard ratios and odds ratios with 95% CIs. Results After scrutinizing 18017 articles, data from ten relevant studies (seven prospective and three retrospective) was extracted. DR was significantly associated with DKD progression with a pooled HR of 2.42 (95% CI: 1.70–3.45) and a pooled OR of 2.62 (95% CI: 1.76–3.89). There was also a significant association between the severity of DR and risk of progression of DKD with a pooled OR of 2.13 (95% CI: 1.82–2.50) for nonproliferative DR and 2.56 (95% CI: 2.93–.33) for proliferative DR. Conclusion Our study suggests that presence of DR is a strong predictor of risk of kidney disease progression in DKD patients. Furthermore, the risk of DKD progression increases with DR severity. Screening for retinal vascular changes could potentially help in prognostication and risk-stratification of patients with DKD.
方法截至2021年9月,在PubMed、Embase和谷歌学者上对符合条件的研究进行系统搜索。使用JBI检查表对所选文章的质量进行评估。Higgins和Thompson的I2统计量用于观察异质性的程度。基于异质性程度,采用固定效应或随机效应模型,采用逆方差法估计混合效应。结果用95%置信区间的危险比和比值比表示。结果在查阅了18017篇文章后,从10项相关研究(7项前瞻性研究和3项回顾性研究)中提取了数据。DR与DKD进展显著相关,合并HR为2.42(95%CI:1.70-3.45),合并OR为2.62(95%CI+1.76-3.89)。DR的严重程度与DKD发展风险之间也存在显著关联,非增殖性DR的合并OR为2.13(95%CI:1.82-2.50),增殖性DR为2.56(95%CI:2.93-.33)。结论我们的研究表明,DR的存在是DKD患者肾脏疾病进展风险的有力预测因素。此外,DKD进展的风险随着DR的严重程度而增加。筛查视网膜血管变化可能有助于DKD患者的预后和风险分层。
{"title":"Diabetic Retinopathy Is a Predictor of Progression of Diabetic Kidney Disease: A Systematic Review and Meta-Analysis","authors":"Mansi Gupta, I. Rao, S. Nagaraju, S. Bhandary, Jayanti Gupta, Ganesh T. C. Babu","doi":"10.1155/2022/3922398","DOIUrl":"https://doi.org/10.1155/2022/3922398","url":null,"abstract":"Methods A systematic search was conducted on PubMed, Embase, and the Google scholar for eligible studies through September 2021. The quality of selected articles was assessed using JBI checklist. Higgins and Thompson's I2 statistic was used to see the degree of heterogeneity. Based on degree of heterogeneity, fixed or random effects model was used to estimate pooled effect using inverse variance method. Results were expressed as hazard ratios and odds ratios with 95% CIs. Results After scrutinizing 18017 articles, data from ten relevant studies (seven prospective and three retrospective) was extracted. DR was significantly associated with DKD progression with a pooled HR of 2.42 (95% CI: 1.70–3.45) and a pooled OR of 2.62 (95% CI: 1.76–3.89). There was also a significant association between the severity of DR and risk of progression of DKD with a pooled OR of 2.13 (95% CI: 1.82–2.50) for nonproliferative DR and 2.56 (95% CI: 2.93–.33) for proliferative DR. Conclusion Our study suggests that presence of DR is a strong predictor of risk of kidney disease progression in DKD patients. Furthermore, the risk of DKD progression increases with DR severity. Screening for retinal vascular changes could potentially help in prognostication and risk-stratification of patients with DKD.","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47091944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Course of Hyperkalemia in Patients on Hemodialysis 血液透析患者高钾血症的病程
IF 2.1 Q3 UROLOGY & NEPHROLOGY Pub Date : 2022-04-28 DOI: 10.1155/2022/6304571
B. Spinowitz, S. Fishbane, M. Fukagawa, M. Ford, Nicolas Guzman, A. Rastogi
Background Evidence of longitudinal serum potassium (sK+) concentrations in hyperkalemic hemodialysis patients is sparse. Objective These post hoc analyses of the placebo arm of the phase 3b DIALIZE study (NCT03303521) explored the course of hyperkalemia in hemodialysis patients receiving placebo. Methods In DIALIZE, 196 patients receiving hemodialysis three times weekly were randomized to placebo or sodium zirconium cyclosilicate 5 g starting dose once daily on nondialysis days for 8 weeks. In these post hoc analyses of placebo patients overall (n = 86) and by predialysis sK+ subgroups at randomization <5.5 mmol/L, 5.5 to <6.0 mmol/L, 6.0 to <6.5 mmol/L, and ≥6.5 mmol/L, we assessed mean predialysis sK+ concentration by visit and the proportions of patients with mean predialysis sK+ ranges of 4.0–5.0 and 4.0–5.5 mmol/L by visit. Results In placebo patients, the mean predialysis sK+ concentration at randomization was 5.9 mmol/L, and 5.8 mmol/L at the end of the study (day 57). For placebo patients overall and across all predialysis sK+ subgroups, the mean predialysis sK+ concentration remained ≥5.0 mmol/L for all visits over 8 weeks. Overall, 7–21% and 27–62% of placebo patients had predialysis sK+ ranges of 4.0–5.0 and 4.0–5.5 mmol/L, respectively, at any visit. The proportions of placebo patients with either predialysis sK+ range were greatest for those who were least hyperkalemic (<5.5 mmol/L) and generally decreased with increasing predialysis sK+ concentration. Conclusions Patients receiving placebo and hemodialysis maintained high predialysis sK+ concentrations over 8 weeks following a hyperkalemic event. Most placebo patients remained hyperkalemic and may be at continued risk of adverse events.
背景高钾血症血液透析患者的纵向血清钾(sK+)浓度的证据很少。目的这些对3b期DIALIZE研究(NCT03303521)安慰剂组的事后分析探讨了接受安慰剂治疗的血液透析患者的高钾血症过程。方法在DIALIZE,196名每周接受三次血液透析的患者被随机分为安慰剂组或硅酸锆钠5组 g起始剂量,在非透析日每天一次,持续8周。在这些安慰剂患者的事后分析中,总体而言(n = 86)和通过预分析sK+亚组在随机化时<5.5 mmol/L,5.5至<6.0 mmol/L,6.0至<6.5 mmol/L,且≥6.5 mmol/L,我们评估了就诊时的平均分析前sK+浓度,以及平均分析前s K+范围为4.0–5.0和4.0–5.5的患者比例 mmol/L。结果在安慰剂患者中,随机化时分析前sK+的平均浓度为5.9 mmol/L和5.8 mmol/L。对于安慰剂患者和所有分析前sK+亚组,分析前sK+的平均浓度保持≥5.0 mmol/L,用于8周以上的所有就诊。总体而言,7-21%和27-62%的安慰剂患者的分析前sK+范围分别为4.0-5.0和4.0-5.5 mmol/L。分析前sK+范围的安慰剂患者比例最高的是那些高钾血症最少的患者(<5.5 mmol/L),并且通常随着分析前sK+浓度的增加而降低。结论接受安慰剂和血液透析的患者在高钾血症事件后的8周内保持高的分析前sK+浓度。大多数安慰剂患者仍然存在高钾血症,并可能持续存在不良事件的风险。
{"title":"Course of Hyperkalemia in Patients on Hemodialysis","authors":"B. Spinowitz, S. Fishbane, M. Fukagawa, M. Ford, Nicolas Guzman, A. Rastogi","doi":"10.1155/2022/6304571","DOIUrl":"https://doi.org/10.1155/2022/6304571","url":null,"abstract":"Background Evidence of longitudinal serum potassium (sK+) concentrations in hyperkalemic hemodialysis patients is sparse. Objective These post hoc analyses of the placebo arm of the phase 3b DIALIZE study (NCT03303521) explored the course of hyperkalemia in hemodialysis patients receiving placebo. Methods In DIALIZE, 196 patients receiving hemodialysis three times weekly were randomized to placebo or sodium zirconium cyclosilicate 5 g starting dose once daily on nondialysis days for 8 weeks. In these post hoc analyses of placebo patients overall (n = 86) and by predialysis sK+ subgroups at randomization <5.5 mmol/L, 5.5 to <6.0 mmol/L, 6.0 to <6.5 mmol/L, and ≥6.5 mmol/L, we assessed mean predialysis sK+ concentration by visit and the proportions of patients with mean predialysis sK+ ranges of 4.0–5.0 and 4.0–5.5 mmol/L by visit. Results In placebo patients, the mean predialysis sK+ concentration at randomization was 5.9 mmol/L, and 5.8 mmol/L at the end of the study (day 57). For placebo patients overall and across all predialysis sK+ subgroups, the mean predialysis sK+ concentration remained ≥5.0 mmol/L for all visits over 8 weeks. Overall, 7–21% and 27–62% of placebo patients had predialysis sK+ ranges of 4.0–5.0 and 4.0–5.5 mmol/L, respectively, at any visit. The proportions of placebo patients with either predialysis sK+ range were greatest for those who were least hyperkalemic (<5.5 mmol/L) and generally decreased with increasing predialysis sK+ concentration. Conclusions Patients receiving placebo and hemodialysis maintained high predialysis sK+ concentrations over 8 weeks following a hyperkalemic event. Most placebo patients remained hyperkalemic and may be at continued risk of adverse events.","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45860507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Nephrology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1